Delivery Order SPE2DB20D3101-SPE2DB23FRQW4

Award Date 7/5/23
Potential Completion Date 7/6/23
Potential Value $212
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $253,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 100mg losartan potassium. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 1, 2023. This delivery order was issued against an existing DLA pharmaceutical supply vehicle to procure a generic hypertension medication for the Department of Defense. Amerisourcebergen will serve as the prime contractor, with no...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a $521 firm fixed price delivery order for 1000 tablets of the generic hypertension medication losartan potassium. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a one-day period of performance beginning August 7th and concluding on August 8th, 2023. The Defense Logistics Agency routinely utilizes indefinite delivery/indefinite quantity contracts...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $61,530 to Amerisourcebergen Drug Corporation for the supply of 1,000 tablets of 100mg losartan potassium. The delivery order was issued against an existing prime vendor contract held by Amerisourcebergen Corporation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania by August 31, 2023. As a major provider of pharmaceuticals to the Department of Defense globally, this order for a...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $901 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to supply 1,000 tablets of the pharmaceutical losartan potassium. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from August 23 to August 24, 2023. No major subcontractors or set aside designations were indicated. The...
The Defense Logistics Agency awarded a delivery order valued at approximately $1,257 to Amerisourcebergen Drug Corporation for 1,000 tablets of 50 mg losartan potassium. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three days from August 11-14, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's Prime Vendor Next contract vehicle, which supports the Defense Logistics Agency's medical supply needs. No...
The Defense Logistics Agency awarded a $844 delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 50mg losartan potassium. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania for delivery by August 9, 2023 in support of the Department of Defense's pharmaceutical supply needs. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the global supply chain for the United States...
The Defense Logistics Agency awarded a $816 delivery order to Amerisourcebergen Drug Corporation for the supply of 1,000 tablets of 50mg losartan potassium. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning June 29 through 30, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the hypertension medication supports the Agency's mission to provide...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $34,800 to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 25mg losartan potassium. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 28-29, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this delivery order for a common hypertension medication supports the Agency's mission to provide...
The Defense Logistics Agency awarded a $270 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 100mg losartan potassium. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 7, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen will deliver the requested pharmaceutical product under the terms of the awarded delivery order. No major subcontractors or set aside designations...
The Defense Logistics Agency awarded a $399.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 100mg losartan potassium. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 27, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this requirement supporting the...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRQW4
    Delivery Order

The Defense Logistics Agency awarded a $211,790 delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 50 mg losartan potassium. The firm fixed price order is for delivery to a Conshohocken, Pennsylvania facility and has a period of performance from July 5-6, 2023. Amerisourcebergen will fulfill the Defense Logistics Agency's requirements for this hypertension medication under an existing indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were identified. The short turnaround time indicates an urgent need to resupply this pharmaceutical to DLA distribution centers supporting Department of Defense health programs.

Generated 12/23/23, 12:56 PM